Literature DB >> 7808772

Utilization of glutathione (L-gamma-glutamyl-L-cysteinylglycine) by Fusobacterium nucleatum subspecies nucleatum.

J Carlsson1, J T Larsen, M B Edlund.   

Abstract

Although fusobacteria use amino acids and peptides as energy source, it is not known whether they are able to actively transport peptides into the cell. In the present study the tripeptide glutathione was used as a model substance to investigate peptide uptake in Fusobacterium nucleatum subsp. nucleatum. Cells harvested after 2 days of growth on blood agar or in their exponential growth phase in broth were suspended in buffer with glutathione, L-cysteinylglycine and L-cysteine. As a measure of cell uptake, the formation of hydrogen sulfide was followed. Cells from blood agar had a low capacity to form hydrogen sulfide from the tripeptide glutathione and the dipeptide L-cysteinylglycine. However, hydrogen sulfide was formed from L-cysteinylglycine, but not from glutathione or from L-cysteine, by cells grown in broth in such a way that it strongly indicated an active transport of L-cysteinylglycine with a Km of 18 microM. Hydrogen sulfide was efficiently formed from glutathione by cells grown in broth in the presence 1 mM glutathione. In these cells a glycylglycine-dependent L-gamma-glutamyl peptidase activity was induced. It is probable that the efficient utilization of glutathione for hydrogen sulfide formation mirrored the uptake of L-cysteinylglycine after an L-gamma-glutamyl peptidase had split L-glutamate off from glutathione.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808772     DOI: 10.1111/j.1399-302x.1994.tb00074.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  10 in total

1.  Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.

Authors:  I L Chapple
Journal:  Clin Mol Pathol       Date:  1996-10

2.  Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease.

Authors:  I L C Chapple; G Brock; C Eftimiadi; J B Matthews
Journal:  Mol Pathol       Date:  2002-12

Review 3.  Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.

Authors:  A I Bolstad; H B Jensen; V Bakken
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

4.  Intergeneric coaggregation of oral Treponema spp. with Fusobacterium spp. and intrageneric coaggregation among Fusobacterium spp.

Authors:  P E Kolenbrander; K D Parrish; R N Andersen; E P Greenberg
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

5.  A 52-kDa leucyl aminopeptidase from treponema denticola is a cysteinylglycinase that mediates the second step of glutathione metabolism.

Authors:  Lianrui Chu; Yanlai Lai; Xiaoping Xu; Scott Eddy; Shuang Yang; Li Song; David Kolodrubetz
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

6.  Glutathione catabolism by Treponema denticola impacts its pathogenic potential.

Authors:  Lianrui Chu; Yimin Wu; Xiaoping Xu; Linda Phillips; David Kolodrubetz
Journal:  Anaerobe       Date:  2020-02-07       Impact factor: 3.331

7.  Effects of Labrador Tea, Peppermint, and Winter Savory Essential Oils on Fusobacterium nucleatum.

Authors:  Amel Ben Lagha; Katy Vaillancourt; Patricia Maquera Huacho; Daniel Grenier
Journal:  Antibiotics (Basel)       Date:  2020-11-10

8.  Proinflammatory and oxidative stress markers in patients with periodontal disease.

Authors:  Ivan Borges; Emília Addison Machado Moreira; Danilo Wilhem Filho; Tiago Bittencourt de Oliveira; Marcelo Barreto Spirelle da Silva; Tânia Silvia Fröde
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

Review 9.  The antioxidant master glutathione and periodontal health.

Authors:  Vivek Kumar Bains; Rhythm Bains
Journal:  Dent Res J (Isfahan)       Date:  2015 Sep-Oct

10.  The proteins of Fusobacterium spp. involved in hydrogen sulfide production from L-cysteine.

Authors:  Amina Basic; Madeleine Blomqvist; Gunnar Dahlén; Gunnel Svensäter
Journal:  BMC Microbiol       Date:  2017-03-14       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.